Menopausal Hot Flash Suppression with a Kappa Opioid Receptor Agonist

被引：0
|
作者：
Reed, Susan D. [1 ]
Clifton, Donald [1 ]
Chavkin, Charles [1 ]
Steiner, Robert A. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
REPRODUCTIVE SCIENCES | 2014年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：88A / 89A
页数：2
相关论文
共 50 条
  • [41] BIPHASIC EFFECT OF A KAPPA-OPIOID RECEPTOR AGONIST ON PLASMA OXYTOCIN LEVELS IN RATS
    GRELL, S
    FJALLAND, B
    CHRISTENSEN, JD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (01) : 41 - 48
  • [42] KETOCYCLAZOCINE, A KAPPA-OPIOID RECEPTOR AGONIST, AND CONTROL OF INTESTINAL MYOELECTRIC ACTIVITY IN DOGS
    TELFORD, GL
    CAUDILL, A
    CONDON, RE
    SZURSZEWSKI, JH
    AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (05): : G566 - G570
  • [43] Antagonists of the kappa opioid receptor
    Urbano, Mariangela
    Guerrero, Miguel
    Rosen, Hugh
    Roberts, Edward
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2021 - 2032
  • [44] Behavioral effects of the kappa opioid receptor partial agonist nalmefene in tests relevant to depression
    Browne, Caroline A.
    Smith, Tiffany
    Lucki, Irwin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 872
  • [45] NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
    O'Connor, Casey
    White, Kate L.
    Doncescu, Nathalie
    Didenko, Tatiana
    Roth, Bryan L.
    Czaplicki, Georges
    Stevens, Raymond C.
    Wuethrich, Kurt
    Milon, Alain
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (38) : 11852 - 11857
  • [46] Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
    Hurramhon Shokirova
    Takenori Inomata
    Tsuyoshi Saitoh
    Jun Zhu
    Kenta Fujio
    Yuichi Okumura
    Ai Yanagawa
    Keiichi Fujimoto
    Jaemyoung Sung
    Atsuko Eguchi
    Maria Miura
    Ken Nagino
    Kunihiko Hirosawa
    Mizu Kuwahara
    Yasutsugu Akasaki
    Hiroshi Nagase
    Akira Murakami
    Scientific Reports, 11
  • [47] MODULATION OF GLUTAMATE RELEASE BY A KAPPA-OPIOID RECEPTOR AGONIST IN RODENT AND PRIMATE STRIATUM
    HILL, MP
    BROTCHIE, JM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) : R1 - R2
  • [48] Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
    Reed, Brian
    Miller, Michael
    Michino, Mayako
    Butelman, Eduardo R.
    Ben-Ezra, Ariel
    Pikus, Philip
    Morochnik, Michelle
    Kim, Yuli
    Ripka, Amy
    Vacca, Joseph
    Kreek, Mary Jeanne
    ACS CHEMICAL NEUROSCIENCE, 2022, : 1849 - 1856
  • [49] Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation
    Shokirova, Hurramhon
    Inomata, Takenori
    Saitoh, Tsuyoshi
    Zhu, Jun
    Fujio, Kenta
    Okumura, Yuichi
    Yanagawa, Ai
    Fujimoto, Keiichi
    Sung, Jaemyoung
    Eguchi, Atsuko
    Miura, Maria
    Nagino, Ken
    Hirosawa, Kunihiko
    Kuwahara, Mizu
    Akasaki, Yasutsugu
    Nagase, Hiroshi
    Murakami, Akira
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Topical treatment with a novel kappa-opioid receptor agonist ameliorates atopic dermatitis
    Schneeweiss, M.
    Luediger, A.
    Chartolani, N.
    Soeberdt, M.
    Knie, U.
    Luger, T. A.
    Abels, C.
    Loser, K.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E47 - E47
12345